Clinical Trial Update: Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intravitreal ranibizumab with or without micropulse laser for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Beijing Hospital | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED